173 related articles for article (PubMed ID: 37152946)
1. Functional brain alterations in Cushing's syndrome.
Papakokkinou E; Ragnarsson O
Front Endocrinol (Lausanne); 2023; 14():1163482. PubMed ID: 37152946
[TBL] [Abstract][Full Text] [Related]
2. Impaired decision-making and selective cortical frontal thinning in Cushing's syndrome.
Crespo I; Esther GM; Santos A; Valassi E; Yolanda VG; De Juan-Delago M; Webb SM; Gómez-Ansón B; Resmini E
Clin Endocrinol (Oxf); 2014 Dec; 81(6):826-33. PubMed ID: 25052342
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric and neurocognitive consequences of endogenous hypercortisolism.
Piasecka M; Papakokkinou E; Valassi E; Santos A; Webb SM; de Vries F; Pereira AM; Ragnarsson O
J Intern Med; 2020 Aug; 288(2):168-182. PubMed ID: 32181937
[TBL] [Abstract][Full Text] [Related]
4. Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome.
Forget H; Lacroix A; Bourdeau I; Cohen H
Psychoneuroendocrinology; 2016 Mar; 65():26-33. PubMed ID: 26708069
[TBL] [Abstract][Full Text] [Related]
5. Decreased prefrontal functional brain response during memory testing in women with Cushing's syndrome in remission.
Ragnarsson O; Stomby A; Dahlqvist P; Evang JA; Ryberg M; Olsson T; Bollerslev J; Nyberg L; Johannsson G
Psychoneuroendocrinology; 2017 Aug; 82():117-125. PubMed ID: 28544904
[TBL] [Abstract][Full Text] [Related]
6. Elevated resting-state connectivity in the medial temporal lobe and the prefrontal cortex among patients with Cushing's syndrome in remission.
Stomby A; Salami A; Dahlqvist P; Evang JA; Ryberg M; Bollerslev J; Olsson T; Johannsson G; Ragnarsson O
Eur J Endocrinol; 2019 May; 180(5):329-338. PubMed ID: 30939453
[TBL] [Abstract][Full Text] [Related]
7. Structural brain abnormalities in Cushing's syndrome.
Bauduin SEEC; van der Wee NJA; van der Werff SJA
Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):285-289. PubMed ID: 29746308
[TBL] [Abstract][Full Text] [Related]
8. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.
Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM
Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405
[TBL] [Abstract][Full Text] [Related]
9. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.
Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A
J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323
[TBL] [Abstract][Full Text] [Related]
10. Altered neural processing of emotional faces in remitted Cushing's disease.
Bas-Hoogendam JM; Andela CD; van der Werff SJ; Pannekoek JN; van Steenbergen H; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; van der Wee NJ; Pereira AM
Psychoneuroendocrinology; 2015 Sep; 59():134-46. PubMed ID: 26092780
[TBL] [Abstract][Full Text] [Related]
11. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.
Crespo I; Santos A; Gómez-Ansón B; López-Mourelo O; Pires P; Vives-Gilabert Y; Webb SM; Resmini E
Endocrine; 2016 Sep; 53(3):848-56. PubMed ID: 27103571
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional brain alterations in Cushing's disease: A narrative review.
Liu YF; Pan L; Feng M
Front Neuroendocrinol; 2022 Oct; 67():101033. PubMed ID: 36126747
[TBL] [Abstract][Full Text] [Related]
13. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
[TBL] [Abstract][Full Text] [Related]
14. Reversible and the irreversible structural alterations on brain after resolution of hypercortisolism in Cushing's disease.
Jiang H; Liu C; Pan SJ; Ren J; He NY; Sun YH; Bian LG; Yan FH; Yang WJ; Sun QF
Steroids; 2019 Nov; 151():108457. PubMed ID: 31326450
[TBL] [Abstract][Full Text] [Related]
15. Improvement in cognitive impairment following the successful treatment of endogenous Cushing's syndrome-a case report and literature review.
Brzozowska MM; Kepreotis S; Tsang F; Fuentes-Patarroyo SX
BMC Endocr Disord; 2019 Jun; 19(1):68. PubMed ID: 31253144
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome.
Na S; Fernandes MA; Ioachimescu AG; Penna S
Behav Neurol; 2020; 2020():4064370. PubMed ID: 32831970
[TBL] [Abstract][Full Text] [Related]
17. Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome.
Resmini E; Santos A; Gómez-Anson B; Vives Y; Pires P; Crespo I; Portella MJ; de Juan-Delago M; Barahona MJ; Webb SM
J Clin Endocrinol Metab; 2012 Feb; 97(2):663-71. PubMed ID: 22162471
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk and white matter lesions after endocrine control of Cushing's syndrome.
Santos A; Resmini E; Gómez-Ansón B; Crespo I; Granell E; Valassi E; Pires P; Vives-Gilabert Y; Martínez-Momblán MA; de Juan M; Mataró M; Webb SM
Eur J Endocrinol; 2015 Dec; 173(6):765-75. PubMed ID: 26497546
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal dysfunction in cured Cushing's syndrome patients, detected by (1) H-MR-spectroscopy.
Resmini E; Santos A; Gómez-Anson B; López-Mourelo O; Pires P; Vives-Gilabert Y; Crespo I; Portella MJ; de Juan-Delago M; Webb SM
Clin Endocrinol (Oxf); 2013 Nov; 79(5):700-7. PubMed ID: 23594250
[TBL] [Abstract][Full Text] [Related]
20. Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.
Gao L; Liu L; Shi L; Luo Y; Wang Z; Guo X; Xing B
Rev Endocr Metab Disord; 2020 Mar; 21(1):185-200. PubMed ID: 31974674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
